BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	523.88	426.86	167.65	141.56	-64.08	854.03
Depreciation & Amortization	91.15	96.43	104.39	101.97	108.04	105.17
Loss (Gain) From Sale of Assets	-	-10	-	-108	-	-52.82
Asset Writedown & Restructuring Costs	22.86	19.89	38.61	-	-	-
Loss (Gain) From Sale of Investments	-7.21	-8.35	-9.23	3.04	5.16	0.57
Stock-Based Compensation	181.02	201.57	207.1	196.31	197.26	189.71
Other Operating Activities	90.04	62.84	-12.71	-62.6	-7.88	-786.36
Change in Accounts Receivable	-112.11	-57.91	-190.44	-82.03	65.57	-59.04
Change in Inventory	-71.05	-63.53	-157.06	-68.26	-35.06	-61.15
Change in Accounts Payable	24.11	-32.24	68.85	59.02	15.69	-87.03
Change in Other Net Operating Assets	-42.43	-62.72	-57.9	-5.1	19.83	-17.72
Operating Cash Flow	700.26	572.84	159.26	175.9	304.54	85.37
Operating Cash Flow Growth	149.95%	259.69%	-9.46%	-42.24%	256.75%	76.88%
Capital Expenditures	-76.09	-85.42	-96.69	-120.96	-95.58	-114.31
Sale (Purchase) of Intangibles	-3.99	-1.99	-10.92	92.74	-23.65	43.95
Investment in Securities	201.43	222.77	-3.63	8.19	-246.09	26.17
Other Investing Activities	1.14	1.14	-	-	-0.99	-9.43
Investing Cash Flow	122.49	136.49	-111.24	-20.03	-366.31	-53.62
Long-Term Debt Issued	-	-	-	-	-	585.75
Long-Term Debt Repaid	-	-494.99	-	-	-3.04	-381.91
Net Debt Issued (Repaid)	-494.99	-494.99	-	-	-3.04	203.84
Issuance of Common Stock	42.08	49.28	69.35	69.33	49.19	71.91
Repurchase of Common Stock	-66.39	-77.56	-76.32	-54.28	-45.81	-94.64
Other Financing Activities	-3.14	-3.18	-11.76	-33.7	-0.4	-
Financing Cash Flow	-522.43	-526.45	-18.73	-18.65	-0.05	181.12
Foreign Exchange Rate Adjustments	1.49	4.83	1.31	0.03	-0.06	-1.15
Net Cash Flow	301.81	187.72	30.6	137.26	-61.88	211.71
Free Cash Flow	624.18	487.42	62.57	54.94	208.96	-28.95
Free Cash Flow Growth	243.29%	679.02%	13.88%	-73.71%	-	-
Free Cash Flow Margin	21.16%	17.08%	2.59%	2.62%	11.32%	-1.56%
Free Cash Flow Per Share	3.18	2.48	0.33	0.29	1.14	-0.15
Cash Interest Paid	8.94	10.36	10.3	10.28	10.4	12.18
Cash Income Tax Paid	65.36	57.27	73.31	54.37	18.15	8.98
Levered Free Cash Flow	411.56	271.54	-17.35	137.32	201.61	-18.77
Unlevered Free Cash Flow	419.05	279.46	-6.52	147.3	211.19	-0.45
Change in Net Working Capital	220.2	287.4	326.5	156.93	-71.56	167.62

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q